RA Capital Management - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 44 filers reported holding DESIGN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
RA Capital Management ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$18,718,755
+9.2%
2,971,2310.0%0.35%
-9.0%
Q1 2023$17,144,003
-43.8%
2,971,2310.0%0.39%
-37.2%
Q4 2022$30,484,830
-34.3%
2,971,231
+7.1%
0.62%
-37.5%
Q3 2022$46,368,000
+51.5%
2,773,231
+26.8%
0.99%
+21.2%
Q2 2022$30,613,000
-13.3%
2,186,6360.0%0.82%
+5.8%
Q1 2022$35,314,000
-24.6%
2,186,6360.0%0.77%
-6.5%
Q4 2021$46,816,000
+45.7%
2,186,6360.0%0.82%
+85.4%
Q3 2021$32,122,000
-26.1%
2,186,6360.0%0.44%
-36.2%
Q2 2021$43,492,000
-33.5%
2,186,6360.0%0.70%
-29.2%
Q1 2021$65,380,0002,186,6360.99%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Logos Global Management LP 2,732,501$81,702,0007.97%
Cormorant Asset Management, LP 5,114,850$146,409,0003.26%
Octagon Capital Advisors LP 250,000$7,475,0002.82%
EcoR1 Capital, LLC 1,137,940$34,024,0001.51%
RA Capital Management 2,186,636$65,380,0000.99%
Avoro Capital Advisors LLC 1,468,318$39,702,0000.69%
Vivo Capital, LLC 530,991$15,877,0000.56%
Rock Springs Capital Management LP 327,250$9,785,0000.21%
Artal Group S.A. 400,000$11,960,0000.21%
Baker Brothers Advisors 1,436,636$42,955,0000.19%
View complete list of DESIGN THERAPEUTICS INC shareholders